STOCK TITAN

[SCHEDULE 13G/A] OptiNose, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Schedule 13G/A filing by Nantahala Capital Management, LLC and two individuals reporting zero beneficial ownership in OptiNose, Inc. The filing states that as of June 30, 2025, Nantahala and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 0 shares of OptiNose common stock (CUSIP 68404V209), representing 0.00% of the class. The filing identifies Nantahala as an investment adviser organized in Massachusetts and lists the reporting persons' business address in New Canaan, Connecticut. Signatures include Nantahala through its Chief Compliance Officer and both individual reporting persons, dated August 14, 2025.

Deposito del modulo Schedule 13G/A da parte di Nantahala Capital Management, LLC e due persone fisiche che riportano zero titolarità effettiva in OptiNose, Inc. Il deposito dichiara che, al 30 giugno 2025, Nantahala e i suoi soci gestori, Wilmot B. Harkey e Daniel Mack, possono essere considerati titolari effettivi di 0 azioni delle azioni ordinarie di OptiNose (CUSIP 68404V209), pari al 0,00% della classe. Il documento identifica Nantahala come consulente per gli investimenti con sede in Massachusetts e indica l'indirizzo commerciale delle persone segnalanti a New Canaan, Connecticut. Le firme includono Nantahala tramite il suo Chief Compliance Officer e i due soggetti individuali, datate 14 agosto 2025.

Presentación del Schedule 13G/A por Nantahala Capital Management, LLC y dos individuos que informan cero propiedad beneficiaria en OptiNose, Inc. La presentación señala que, a fecha del 30 de junio de 2025, Nantahala y sus miembros gestores, Wilmot B. Harkey y Daniel Mack, pueden considerarse propietarios beneficiarios de 0 acciones de las acciones ordinarias de OptiNose (CUSIP 68404V209), representando el 0,00% de la clase. El documento identifica a Nantahala como asesor de inversiones organizado en Massachusetts y lista la dirección comercial de las personas informantes en New Canaan, Connecticut. Las firmas incluyen a Nantahala a través de su Chief Compliance Officer y ambos informantes individuales, con fecha 14 de agosto de 2025.

Nantahala Capital Management, LLC 및 두 개인이 OptiNose, Inc.에 대한 실질적 소유권이 '0'임을 보고하는 Schedule 13G/A 제출 제출서류에 따르면, 2025년 6월 30일 기준 Nantahala와 그 관리 멤버인 Wilmot B. Harkey 및 Daniel Mack는 OptiNose 보통주(CUSIP 68404V209) 0주의 실질적 소유자로 간주될 수 있으며, 이는 해당 클래스의 0.00%에 해당합니다. 해당 서류는 Nantahala를 매사추세츠에 설립된 투자자문사로 식별하며, 보고인의 업무 주소를 코네티컷주 뉴케이넌으로 기재하고 있습니다. 서명은 Nantahala의 Chief Compliance Officer와 두 명의 개인 보고자가 포함되어 있으며, 날짜는 2025년 8월 14일입니다.

Dépôt du formulaire Schedule 13G/A par Nantahala Capital Management, LLC et deux personnes physiques déclarant une propriété bénéficiaire nulle dans OptiNose, Inc. Le dépôt indique qu'au 30 juin 2025, Nantahala et ses membres dirigeants, Wilmot B. Harkey et Daniel Mack, peuvent être considérés comme détenteurs bénéficiaires de 0 actions des actions ordinaires d'OptiNose (CUSIP 68404V209), représentant 0,00% de la catégorie. Le document identifie Nantahala comme un conseiller en investissement organisé dans le Massachusetts et mentionne l'adresse professionnelle des personnes déclarante à New Canaan, Connecticut. Les signatures comprennent Nantahala via son Chief Compliance Officer et les deux personnes physiques déclarantes, datées du 14 août 2025.

Einreichung des Schedule 13G/A durch Nantahala Capital Management, LLC und zwei Einzelpersonen mit Angabe eines wirtschaftlichen Eigentums von null an OptiNose, Inc. Die Einreichung besagt, dass Nantahala und seine geschäftsführenden Mitglieder, Wilmot B. Harkey und Daniel Mack, zum 30. Juni 2025 als wirtschaftliche Eigentümer von 0 Aktien der Stammaktien von OptiNose (CUSIP 68404V209) gelten können, was 0,00% der Klasse entspricht. Das Dokument identifiziert Nantahala als Investmentberater mit Sitz in Massachusetts und nennt die Geschäftsadresse der meldenden Personen in New Canaan, Connecticut. Unterzeichnet ist die Einreichung von Nantahala über seinen Chief Compliance Officer sowie von beiden meldepflichtigen Personen, datiert auf den 14. August 2025.

Positive
  • Complete disclosure of reporting persons, addresses, and CUSIP with signed certifications dated August 14, 2025
Negative
  • None.

Insights

TL;DR: The filing shows no economic stake by the reporting persons in OPTN, so there is no ownership-driven influence on the company.

The Schedule 13G/A discloses that Nantahala Capital Management and its named managers hold 0 shares (0.00%) of OptiNose as of June 30, 2025. For investors and analysts, this is a routine ownership disclosure indicating the filer is not a shareholder and therefore not an active investor exerting voting or dispositive influence. There are no financial metrics, transactions, or changes in ownership reported that would affect valuation or control.

TL;DR: Filing appears complete and compliant: reporting persons certified ordinary-course holdings and executed signatures.

The document classifies Nantahala as an investment adviser and includes the required certification that the securities, if any, are held in the ordinary course of business. All required identification fields are provided, including issuer address and CUSIP. The signed certifications dated August 14, 2025, satisfy typical Schedule 13G/A formalities. Because no shares are reported, there is no disclosure of group formation, material influence, or Section 13(d) activity to assess for risk.

Deposito del modulo Schedule 13G/A da parte di Nantahala Capital Management, LLC e due persone fisiche che riportano zero titolarità effettiva in OptiNose, Inc. Il deposito dichiara che, al 30 giugno 2025, Nantahala e i suoi soci gestori, Wilmot B. Harkey e Daniel Mack, possono essere considerati titolari effettivi di 0 azioni delle azioni ordinarie di OptiNose (CUSIP 68404V209), pari al 0,00% della classe. Il documento identifica Nantahala come consulente per gli investimenti con sede in Massachusetts e indica l'indirizzo commerciale delle persone segnalanti a New Canaan, Connecticut. Le firme includono Nantahala tramite il suo Chief Compliance Officer e i due soggetti individuali, datate 14 agosto 2025.

Presentación del Schedule 13G/A por Nantahala Capital Management, LLC y dos individuos que informan cero propiedad beneficiaria en OptiNose, Inc. La presentación señala que, a fecha del 30 de junio de 2025, Nantahala y sus miembros gestores, Wilmot B. Harkey y Daniel Mack, pueden considerarse propietarios beneficiarios de 0 acciones de las acciones ordinarias de OptiNose (CUSIP 68404V209), representando el 0,00% de la clase. El documento identifica a Nantahala como asesor de inversiones organizado en Massachusetts y lista la dirección comercial de las personas informantes en New Canaan, Connecticut. Las firmas incluyen a Nantahala a través de su Chief Compliance Officer y ambos informantes individuales, con fecha 14 de agosto de 2025.

Nantahala Capital Management, LLC 및 두 개인이 OptiNose, Inc.에 대한 실질적 소유권이 '0'임을 보고하는 Schedule 13G/A 제출 제출서류에 따르면, 2025년 6월 30일 기준 Nantahala와 그 관리 멤버인 Wilmot B. Harkey 및 Daniel Mack는 OptiNose 보통주(CUSIP 68404V209) 0주의 실질적 소유자로 간주될 수 있으며, 이는 해당 클래스의 0.00%에 해당합니다. 해당 서류는 Nantahala를 매사추세츠에 설립된 투자자문사로 식별하며, 보고인의 업무 주소를 코네티컷주 뉴케이넌으로 기재하고 있습니다. 서명은 Nantahala의 Chief Compliance Officer와 두 명의 개인 보고자가 포함되어 있으며, 날짜는 2025년 8월 14일입니다.

Dépôt du formulaire Schedule 13G/A par Nantahala Capital Management, LLC et deux personnes physiques déclarant une propriété bénéficiaire nulle dans OptiNose, Inc. Le dépôt indique qu'au 30 juin 2025, Nantahala et ses membres dirigeants, Wilmot B. Harkey et Daniel Mack, peuvent être considérés comme détenteurs bénéficiaires de 0 actions des actions ordinaires d'OptiNose (CUSIP 68404V209), représentant 0,00% de la catégorie. Le document identifie Nantahala comme un conseiller en investissement organisé dans le Massachusetts et mentionne l'adresse professionnelle des personnes déclarante à New Canaan, Connecticut. Les signatures comprennent Nantahala via son Chief Compliance Officer et les deux personnes physiques déclarantes, datées du 14 août 2025.

Einreichung des Schedule 13G/A durch Nantahala Capital Management, LLC und zwei Einzelpersonen mit Angabe eines wirtschaftlichen Eigentums von null an OptiNose, Inc. Die Einreichung besagt, dass Nantahala und seine geschäftsführenden Mitglieder, Wilmot B. Harkey und Daniel Mack, zum 30. Juni 2025 als wirtschaftliche Eigentümer von 0 Aktien der Stammaktien von OptiNose (CUSIP 68404V209) gelten können, was 0,00% der Klasse entspricht. Das Dokument identifiziert Nantahala als Investmentberater mit Sitz in Massachusetts und nennt die Geschäftsadresse der meldenden Personen in New Canaan, Connecticut. Unterzeichnet ist die Einreichung von Nantahala über seinen Chief Compliance Officer sowie von beiden meldepflichtigen Personen, datiert auf den 14. August 2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Nantahala Capital Management, LLC
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:08/14/2025
Wilmot B. Harkey
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:08/14/2025
Daniel Mack
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:08/14/2025

FAQ

What does the Schedule 13G/A filed for OPTN disclose?

The filing discloses that Nantahala Capital Management, Wilmot B. Harkey, and Daniel Mack report 0 shares beneficially owned in OptiNose as of June 30, 2025, representing 0.00% of the class.

Who filed the Schedule 13G/A for OptiNose (OPTN)?

The filing was made by Nantahala Capital Management, LLC and reporting individuals Wilmot B. Harkey and Daniel Mack.

When is the ownership measurement date reported in the Schedule 13G/A?

The filing reports ownership as of June 30, 2025.

Does the Schedule 13G/A indicate Nantahala has control or a group with other holders?

No. The filing states 0 shares owned and lists Group-related items as not applicable or unchecked.

Were the required signatures provided on the Schedule 13G/A for OPTN?

Yes. The form is signed by Taki Vasilakis for Nantahala as Chief Compliance Officer and by both Wilmot B. Harkey and Daniel Mack on August 14, 2025.
Optinose

NASDAQ:OPTN

OPTN Rankings

OPTN Latest News

OPTN Latest SEC Filings

OPTN Stock Data

96.41M
9.47M
7.17%
72.66%
2.42%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
YARDLEY